BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30347597)

  • 1. Downregulation of long noncoding RNA PVT1 attenuates paclitaxel resistance in glioma cells.
    Song T; Yan L; Cai K; Zhao T; Xu M
    Cancer Biomark; 2018; 23(3):447-453. PubMed ID: 30347597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA-PVT1 was identified as a key regulator for TMZ resistance and STAT-related pathway in glioma.
    Chen Y; Ma F; Zhang Z; Guo Y; Shen H; Chen H
    BMC Cancer; 2023 May; 23(1):455. PubMed ID: 37202742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling Pathway.
    Guo JL; Tang T; Li JH; Yang YH; Zhang L; Quan Y
    Pathol Oncol Res; 2020 Jul; 26(3):1757-1766. PubMed ID: 31650338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2.
    Yang A; Wang H; Yang X
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PVT1 regulates the malignant behaviors of human glioma cells by targeting miR-190a-5p and miR-488-3p.
    Xue W; Chen J; Liu X; Gong W; Zheng J; Guo X; Liu Y; Liu L; Ma J; Wang P; Li Z; Xue Y
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1783-1794. PubMed ID: 29501773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
    Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
    Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
    Kong R; Zhang EB; Yin DD; You LH; Xu TP; Chen WM; Xia R; Wan L; Sun M; Wang ZX; De W; Zhang ZH
    Mol Cancer; 2015 Apr; 14():82. PubMed ID: 25890171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of Long Noncoding RNA Plasmacytoma Variant Translocation 1 with Antisense Locked Nucleic Acid GapmeRs Exerts Tumor-Suppressive Functions in Human Acute Erythroleukemia Cells Through Downregulation of
    Salehi M; Sharifi M; Bagheri M
    Cancer Biother Radiopharm; 2019 Aug; 34(6):371-379. PubMed ID: 30141968
    [No Abstract]   [Full Text] [Related]  

  • 11. Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
    Zheng Y; Tian X; Wang T; Xia X; Cao F; Tian J; Xu P; Ma J; Xu H; Wang S
    Mol Cancer; 2019 Mar; 18(1):61. PubMed ID: 30925926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma.
    Zhao W; Sun C; Cui Z
    Clin Transl Oncol; 2017 Jun; 19(6):735-741. PubMed ID: 28105536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA PVT1 aggravates the progression of glioma via downregulating UPF1.
    Lv ZH; Wang ZY; Li ZY
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8956-8963. PubMed ID: 31696483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression.
    Li Z; Li M; Xia P; Wang L; Lu Z
    Cancer Biol Ther; 2022 Dec; 23(1):225-233. PubMed ID: 35275031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA PVT1: a Novel Therapeutic Target for Cancers.
    Pan X; Zheng G; Gao C
    Clin Lab; 2018 May; 64(5):655-662. PubMed ID: 29739059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells.
    Zhang M; Liu S; Fu C; Wang X; Zhang M; Liu G; Dai C; Gong Z; Xu H; Fu Z; Xu P; Xu J; Jia X
    Cancer Biother Radiopharm; 2019 Jun; 34(5):316-324. PubMed ID: 30892073
    [No Abstract]   [Full Text] [Related]  

  • 18. Long non‑coding RNA plasmacytoma variant translocation 1 gene promotes the development of cervical cancer via the NF‑κB pathway.
    Wang C; Zou H; Yang H; Wang L; Chu H; Jiao J; Wang Y; Chen A
    Mol Med Rep; 2019 Sep; 20(3):2433-2440. PubMed ID: 31322217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of long non‑coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells.
    Fan H; Zhu JH; Yao XQ
    Mol Med Rep; 2018 Jun; 17(6):8309-8315. PubMed ID: 29693171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the expression of long non-coding RNA PVT1 in glioma.
    Fang J; Huang J
    Cancer Biomark; 2019; 24(4):509-513. PubMed ID: 30909189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.